These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 11747596)
21. Caspase-3 as a therapeutic target for heart failure. Yang B; Ye D; Wang Y Expert Opin Ther Targets; 2013 Mar; 17(3):255-63. PubMed ID: 23294432 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice. Hayakawa Y; Chandra M; Miao W; Shirani J; Brown JH; Dorn GW; Armstrong RC; Kitsis RN Circulation; 2003 Dec; 108(24):3036-41. PubMed ID: 14638549 [TBL] [Abstract][Full Text] [Related]
23. Calpain and caspase-3 inhibitors reduce infarct size and post-ischemic apoptosis in rat heart without modifying contractile recovery. Perrin C; Ecarnot-Laubriet A; Vergely C; Rochette L Cell Mol Biol (Noisy-le-grand); 2003; 49 Online Pub():OL497-505. PubMed ID: 14995081 [TBL] [Abstract][Full Text] [Related]
27. A mechanistic role for cardiac myocyte apoptosis in heart failure. Wencker D; Chandra M; Nguyen K; Miao W; Garantziotis S; Factor SM; Shirani J; Armstrong RC; Kitsis RN J Clin Invest; 2003 May; 111(10):1497-504. PubMed ID: 12750399 [TBL] [Abstract][Full Text] [Related]
28. Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart : prospects for molecular ventricular assistance. Shah AS; Lilly RE; Kypson AP; Tai O; Hata JA; Pippen A; Silvestry SC; Lefkowitz RJ; Glower DD; Koch WJ Circulation; 2000 Feb; 101(4):408-14. PubMed ID: 10653833 [TBL] [Abstract][Full Text] [Related]
29. Ultrastructural changes associated with myocardial apoptosis, in failing rat hearts induced by volume overload. Treskatsch S; Shakibaei M; Feldheiser A; Shaqura M; Dehe L; Roepke TK; Spies C; Schäfer M; Mousa SA Int J Cardiol; 2015 Oct; 197():327-32. PubMed ID: 26159040 [TBL] [Abstract][Full Text] [Related]
30. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Smith RS; Agata J; Xia CF; Chao L; Chao J Life Sci; 2005 Apr; 76(21):2457-71. PubMed ID: 15763077 [TBL] [Abstract][Full Text] [Related]
31. Sarcomeric dysfunction in heart failure. Hamdani N; Kooij V; van Dijk S; Merkus D; Paulus WJ; Remedios CD; Duncker DJ; Stienen GJ; van der Velden J Cardiovasc Res; 2008 Mar; 77(4):649-58. PubMed ID: 18055579 [TBL] [Abstract][Full Text] [Related]
32. Novel technique of aortic banding followed by gene transfer during hypertrophy and heart failure. Del Monte F; Butler K; Boecker W; Gwathmey JK; Hajjar RJ Physiol Genomics; 2002; 9(1):49-56. PubMed ID: 11948290 [TBL] [Abstract][Full Text] [Related]
33. Enhanced cardiac contractility after gene transfer of V2 vasopressin receptors In vivo by ultrasound-guided injection or transcoronary delivery. Weig HJ; Laugwitz KL; Moretti A; Kronsbein K; Städele C; Brüning S; Seyfarth M; Brill T; Schömig A; Ungerer M Circulation; 2000 Apr; 101(13):1578-85. PubMed ID: 10747352 [TBL] [Abstract][Full Text] [Related]
34. Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery. Maurice JP; Hata JA; Shah AS; White DC; McDonald PH; Dolber PC; Wilson KH; Lefkowitz RJ; Glower DD; Koch WJ J Clin Invest; 1999 Jul; 104(1):21-9. PubMed ID: 10393695 [TBL] [Abstract][Full Text] [Related]
35. Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes. de Moissac D; Gurevich RM; Zheng H; Singal PK; Kirshenbaum LA J Mol Cell Cardiol; 2000 Jan; 32(1):53-63. PubMed ID: 10652190 [TBL] [Abstract][Full Text] [Related]
36. Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study. Trappe K; Thomas D; Bikou O; Kelemen K; Lugenbiel P; Voss F; Becker R; Katus HA; Bauer A Eur Heart J; 2013 Jan; 34(2):147-57. PubMed ID: 21785105 [TBL] [Abstract][Full Text] [Related]
37. S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction. Pleger ST; Remppis A; Heidt B; Völkers M; Chuprun JK; Kuhn M; Zhou RH; Gao E; Szabo G; Weichenhan D; Müller OJ; Eckhart AD; Katus HA; Koch WJ; Most P Mol Ther; 2005 Dec; 12(6):1120-9. PubMed ID: 16168714 [TBL] [Abstract][Full Text] [Related]
38. S100A1 gene transfer in myocardium. Pleger ST; Most P; Heidt B; Voelkers M; Hata JA; Katus HA; Remppis A; Koch WJ Eur J Med Res; 2006 Oct; 11(10):418-22. PubMed ID: 17107875 [TBL] [Abstract][Full Text] [Related]
39. Pharmacology of caspase inhibitors in rabbit cardiomyocytes subjected to metabolic inhibition and recovery. Li HL; Karwatowska-Prokopczuk E; Mutomba M; Wu J; Karanewsky D; Valentino K; Engler RL; Gottlieb RA Antioxid Redox Signal; 2001 Feb; 3(1):113-23. PubMed ID: 11294190 [TBL] [Abstract][Full Text] [Related]